Clinical implications of hypoxia inducible factor in renal cell carcinoma.
about
Association between HIF-1α C1772T/G1790A polymorphisms and cancer susceptibility: an updated systematic review and meta-analysis based on 40 case-control studiesThe association between the rs11549465 polymorphism in the hif-1α gene and cancer risk: a meta-analysisHypoxia-inducible factor-1alpha gene polymorphisms and cancer risk: a meta-analysis.Role of hypoxia and glycolysis in the development of multi-drug resistance in human tumor cells and the establishment of an orthotopic multi-drug resistant tumor model in nude mice using hypoxic pre-conditioning.Associations between C1772T polymorphism in hypoxia-inducible factor-1α gene and breast cancer: a meta-analysis.Hypoxia-inducible factor-1α polymorphisms and risk of cancer metastasis: a meta-analysis.miR-23b targets proline oxidase, a novel tumor suppressor protein in renal cancerEmetine promotes von Hippel-Lindau-independent degradation of hypoxia-inducible factor-2α in clear cell renal carcinoma.Combined Influence of EGF+61G>A and TGFB+869T>C Functional Polymorphisms in Renal Cell Carcinoma Progression and Overall Survival: The Link to Plasma Circulating MiR-7 and MiR-221/222 Expression.Emerging molecular classification in renal cell carcinoma: implications for drug development.Potential role of (124)I-girentuximab in the presurgical diagnosis of clear-cell renal cell cancerTargeting HIF2α translation with Tempol in VHL-deficient clear cell renal cell carcinoma.Genetic profiles in renal tumors.Alterations in VHL as potential biomarkers in renal-cell carcinoma.Kidney cancer pathology in the new context of targeted therapy.How far is the horizon? From current targets to future drugs in advanced renal cancer.Renal cell carcinoma development and miRNAs: a possible link to the EGFR pathway.Association between HIF1A rs11549465 polymorphism and risk of prostate cancer: a meta-analysis.No association of the hypoxia-inducible factor-1α gene polymorphisms with survival in patients with colorectal cancer.Pan-PI-3 kinase inhibitor SF1126 shows antitumor and antiangiogenic activity in renal cell carcinoma.Expression of micro-RNAs and genes related to angiogenesis in ccRCC and associations with tumor characteristics.Plasmatic miR-210, miR-221 and miR-1233 profile: potential liquid biopsies candidates for renal cell carcinoma.Circulating biomarkers in renal cell carcinoma: the link between microRNAs and extracellular vesicles, where are we now?
P2860
Q27012640-106603E9-2BEF-418E-8448-0B4404663177Q28083642-592C187A-693B-45E0-9B61-CD30AD4B2B1AQ33582902-27D6D40B-A770-41A7-9DEC-07DB3B4ECFAFQ34610733-7928A583-D465-4D4B-BA81-526235ACB496Q34701515-92EC1C7D-DCE5-4DED-8DBC-5967B879C0B8Q34981274-3B6CEAD3-B6C1-4083-85C3-CF569C7A989CQ35438578-1E9043DC-A694-4856-88B9-7A80B0195DA4Q35454927-C32CD16F-46A1-43FC-8164-F95358E5CA34Q35535686-A3FCBCCB-3F75-4A6C-9920-B1DC7CED712AQ36084718-7084E8C3-1B90-4B9B-9E15-7E71A2560BBEQ36429759-D92EBA62-086F-47D4-9FA0-A036F3A3F5DFQ37030920-35C28BEA-1673-4AA5-BB75-1E39E48A73EFQ37615533-C88E36FC-BB49-4D29-9B0A-8468BE5DD75AQ37724576-F041B76B-21F0-4116-8430-E78744BA0EE1Q37890209-479D05D3-388D-45E2-A346-3B072F3D578AQ38105251-168D4138-E54D-4498-A0E4-7E36459D5029Q38160090-15300572-2172-4AD7-9838-56ABA8ED5C79Q38371345-27CE2060-38FE-432A-9222-E8E6659A8502Q38483394-04B26185-215C-423F-A87E-202CC6063C40Q38921200-03DC0FB2-733E-4576-9626-08DDF98AF94DQ47163897-7E883424-C1B9-48F9-8D7C-ACF33CD0EC7BQ47359451-3B3C6E8F-2388-47F0-8D6A-F17BEC55AE08Q51854381-79BCC499-6D48-4287-86BD-A129612D371A
P2860
Clinical implications of hypoxia inducible factor in renal cell carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinical implications of hypoxia inducible factor in renal cell carcinoma.
@en
Clinical implications of hypoxia inducible factor in renal cell carcinoma.
@nl
type
label
Clinical implications of hypoxia inducible factor in renal cell carcinoma.
@en
Clinical implications of hypoxia inducible factor in renal cell carcinoma.
@nl
prefLabel
Clinical implications of hypoxia inducible factor in renal cell carcinoma.
@en
Clinical implications of hypoxia inducible factor in renal cell carcinoma.
@nl
P1433
P1476
Clinical implications of hypoxia inducible factor in renal cell carcinoma
@en
P2093
Marc C Smaldone
P304
P356
10.1016/J.UROLONC.2007.12.001
P577
2009-05-01T00:00:00Z